The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 04, 2017
Filed:
Sep. 09, 2011
Hisashi Narimatsu, Ibaraki, JP;
Akira Togayachi, Ibaraki, JP;
Yuzuru Ikehara, Ibaraki, JP;
Hiroyuki Kaji, Ibaraki, JP;
Atsushi Kuno, Ibaraki, JP;
Takashi Ohkura, Ibaraki, JP;
Hideki Matsuzaki, Ibaraki, JP;
Yoshitoshi Hirao, Ibaraki, JP;
Jun Iwaki, Ibaraki, JP;
Minako Abe, Ibaraki, JP;
Masaharu Nomura, Tokyo, JP;
Masayuki Noguchi, Ibaraki, JP;
Hisashi Narimatsu, Ibaraki, JP;
Akira Togayachi, Ibaraki, JP;
Yuzuru Ikehara, Ibaraki, JP;
Hiroyuki Kaji, Ibaraki, JP;
Atsushi Kuno, Ibaraki, JP;
Takashi Ohkura, Ibaraki, JP;
Hideki Matsuzaki, Ibaraki, JP;
Yoshitoshi Hirao, Ibaraki, JP;
Jun Iwaki, Ibaraki, JP;
Minako Abe, Ibaraki, JP;
Masaharu Nomura, Tokyo, JP;
Masayuki Noguchi, Ibaraki, JP;
National Institute of Advanced Industrial Science and Technology, Tokyo, JP;
Tokyo Medical University, Tokyo, JP;
Abstract
An object of the present invention is to develop and provide a lung cancer differential marker with which lung cancer can be diagnosed conveniently and highly sensitively without depending only on increase or decrease in protein expression level between cancer patients and healthy persons. Another object of the present invention is to develop and provide a glycan marker capable of distinguishing histological types of lung cancer. Of serum glycoproteins, glycopeptide and glycoprotein groups whose glycan structures were altered specifically in lung cancer cell culture supernatants were identified, and they are provided as lung cancer differential markers.